MD
Assistant Professor, Hematology
School of Medicine
UNC-Chapel Hill
Immunology
Area of Interest
Eben Lichtman, MD, focuses his research on the development of chimeric antigen receptor T-cell therapies for patients with acute myeloid leukemia and multiple myeloma.
Awards and Honors
- American Society for Clinical Oncology (ASCO) Young Investigator Award, 2018
- First place poster award, translational research category, UNC Lineberger Annual Retreat, 2017
- Outstanding Fellow Award, North Carolina Oncology Association, 2017
- Selected to participate in American Association for Cancer Research (AACR)/ASCO Molecular Biology in Clinical Oncology Workshop, Snowmass, CO, 2017
- Selected for Immunotherapy T32 Training Grant, UNC-Chapel Hill, 2017
- Selected to participate in AACR/ASCO Methods in Clinical Cancer Research Workshop, Vail, CO, 2016
